Cargando…

CD4(+) T cell counts and soluble programmed death-1 at baseline correlated with hepatitis B surface antigen decline in HIV/HBV coinfection during combined antiretroviral therapy

BACKGROUND: Several studies have described the rapid decline and clearance of hepatitis B surface antigen (HBsAg) in human immunodeficiency virus (HIV)/hepatitis B virus (HBV) coinfection after initiating combined antiretroviral therapy (cART). Early decline of HBsAg levels is associated with HBsAg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaodi, Xu, Ling, Lu, Lianfeng, Liu, Xiaosheng, Yang, Yang, Wu, Yuanni, Han, Yang, Li, Xiaoxia, Li, Yanling, Song, Xiaojing, Cao, Wei, Li, Taisheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189149/ https://www.ncbi.nlm.nih.gov/pubmed/37207191 http://dx.doi.org/10.3389/fcimb.2023.1178788

Ejemplares similares

HBV pgRNA profiles in Chinese HIV/HBV coinfected patients under pre‐ and posttreatment: a multicentre observational cohort study
por: Xu, Ling, et al.
Publicado: (2022)

Altered plasma metabolites and inflammatory networks in HIV-1 infected patients with different immunological responses after long-term antiretroviral therapy
por: Lu, Lianfeng, et al.
Publicado: (2023)

Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis
por: Liu, Xiaosheng, et al.
Publicado: (2023)

Immune Responses to HBV Vaccine in People Living with HIV (PLWHs) Who Achieved Successful Treatment: A Prospective Cohort Study
por: Xu, Ling, et al.
Publicado: (2023)

Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
por: Gu, Lijun, et al.
Publicado: (2015)

Comparison of Renal Function Biomarkers of Serum Creatinine and Cystatin C in HIV-Infected People on Dolutegravir-Containing Therapy
por: Lu, Lianfeng, et al.
Publicado: (2022)

Comparative Transcriptional Analysis Identified Characteristic Genes and Patterns in HIV-Infected Immunological Non-Responders
por: Liu, Xiaosheng, et al.
Publicado: (2022)

The pattern and magnitude of T cell subsets reconstitution during ten years of ART with viral suppression in HIV-infected patients
por: Lu, Lianfeng, et al.
Publicado: (2022)

Incidence and predictors of HBV functional cure in patients with HIV/HBV coinfection: A retrospective cohort study
por: Zhang, Qingrong, et al.
Publicado: (2023)

HBV influence on Response to Antiretroviral Therapy in Horizontally HIV-HBV Coinfected Patient during Early Childhood
por: Niculescu, Irina, et al.
Publicado: (2013)

Immunological changes after COVID-19 vaccination in an HIV-positive patient
por: Gong, Changlin, et al.
Publicado: (2022)

Safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection: a systematic review and meta-analysis protocol
por: Wu, Yuan-ni, et al.
Publicado: (2022)

Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease
por: Guo, Fuping, et al.
Publicado: (2017)

Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
por: Avihingsanon, Anchalee, et al.
Publicado: (2012)

Week 120 Efficacy of Tenofovir, Lamivudine and Lopinavir/r-Based Second-Line Antiretroviral Therapy in Treatment-Experienced HIV Patients
por: Han, Yang, et al.
Publicado: (2015)

Hepatitis B and HIV coinfection in Northern Uganda: Is a decline in HBV prevalence on the horizon?
por: Chiesa, Annacarla, et al.
Publicado: (2020)

High rates of hepatitis B virus (HBV) functional cure among HIV/HBV coinfected Chinese adults on antiretroviral therapy
por: Xia, Huan, et al.
Publicado: (2022)

Treatment effects of the differential first-line antiretroviral regimens among HIV/HBV coinfected patients in southwest China: an observational study
por: Zhu, Jinhui, et al.
Publicado: (2019)

Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection
por: Kiweewa, Flavia Matovu, et al.
Publicado: (2022)

Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection
por: Zou, Xiaojing, et al.
Publicado: (2021)

HBV reactivation and its effect on survival in HBV-related hepatocarcinoma patients undergoing transarterial chemoembolization combined with tyrosine kinase inhibitors plus immune checkpoint inhibitors
por: Shen, Jiaming, et al.
Publicado: (2023)

Naïve CD4(+) cell counts significantly decay and high HIV RNA levels contribute to immunological progression in long-term non-progressors infected with HIV by blood products: a cohort study
por: Xu, Ling, et al.
Publicado: (2021)

Risk factors and longitudinal changes of dyslipidemia among Chinese people living with HIV receiving antiretroviral therapy
por: Li, Xiuxia, et al.
Publicado: (2023)

Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients
por: Adriaensen, Wim, et al.
Publicado: (2018)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

High-sensitivity HBV DNA test for the diagnosis of occult HBV infection: commonly used but not reliable
por: Wang, Chengwei, et al.
Publicado: (2023)

Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis
por: Yang, Shanshan, et al.
Publicado: (2022)

NKG2C(+) natural killer cell function improves the control of HBV replication in individuals with acute HIV infection coinfected with HBV
por: Song, Ting, et al.
Publicado: (2020)

Acute Immune Reconstitution Inflammatory Syndrome-HBV Flare in an HIV/HBV Coinfected Patient After Antiretroviral Therapy Initiation: Case Report and Literature Review
por: Arshad, Iqra, et al.
Publicado: (2023)

INCIDENCE OF COINFECTION IN PATIENTS WITH COVID-19
por: Aleman, Valeria Demeneghi, et al.
Publicado: (2020)

Chances for cure in chronic HBV/HDV coinfection
por: Iliescu, Gabriela, et al.
Publicado: (2014)

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
por: Bihl, Florian, et al.
Publicado: (2015)

Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects
por: Li, Yijia, et al.
Publicado: (2016)

Determinants of Coinfection in the Mycoviruses
por: Thapa, Vaskar, et al.
Publicado: (2019)

Role of Epstein-Barr Virus and Human Papillomavirus Coinfection in Cervical Intraepithelial Neoplasia in Chinese Women Living With HIV
por: Feng, Min, et al.
Publicado: (2021)

TB AND COVID-19 COINFECTION: A CASE SERIES
por: CÎRJALIU, R.-E., et al.
Publicado: (2022)

Bone turnover and bone mineral density in HIV-1 infected Chinese taking highly active antiretroviral therapy –a prospective observational study
por: Zhang, Lixia, et al.
Publicado: (2013)

HIV-HBV Coinfection—Current Challenges for Virologic Monitoring
por: Ruta, Simona, et al.
Publicado: (2023)

Effect of Goose Parvovirus and Duck Circovirus Coinfection in Ducks
por: Liu, Jie, et al.
Publicado: (2020)

Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese HIV/AIDS Patients: Multicentric Observation Cohort
por: Li, Taisheng, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_a0gsvkmn19a1j0ukmj76bhk0po